The chemical substance with the name "H-TYR-LYS-GLY-ARG-CYCLO(-GLU-TYR-ILE-LYS)-LEU-ILE-THR-ARG-PRO-ARG-TYR-NH2" and CAS number "185032-24-0" is a synthetic peptide. It is characterized by a sequence of amino acids that includes both linear and cyclic components, which contribute to its structural stability and biological activity. The presence of various amino acids such as tyrosine (Tyr), lysine (Lys), arginine (Arg), and others indicates potential roles in biological processes, including signaling and interaction with receptors. The cyclic structure formed by the cyclization of certain residues enhances its resistance to enzymatic degradation, making it more stable in physiological conditions. This peptide may exhibit specific pharmacological properties, potentially acting as a modulator in various biological pathways. Its design suggests applications in therapeutic contexts, particularly in areas related to peptide-based drugs or research in biochemistry and molecular biology. Further studies would be necessary to elucidate its precise mechanisms of action and potential uses in clinical settings.

H-TYR-LYS-GLY-ARG-CYCLO(-GLU-TYR-ILE-LYS)-LEU-ILE-THR-ARG-PRO-ARG-TYR-NH2

185032-24-0: The chemical substance with the name "H-TYR-LYS-GLY-ARG-CYCLO(-GLU-TYR-ILE-LYS)-LEU-ILE-THR-ARG-PRO-ARG-TYR-NH2" and CAS number "185032-24-0" is a synthetic peptide. It is characterized by a sequence of amino acids that includes both linear and cyclic components, which contribute to its structural stability and biological activity. The presence of various amino acids such as tyrosine (Tyr), lysine (Lys), arginine (Arg), and others indicates potential roles in biological processes, including signaling and interaction with receptors. The cyclic structure formed by the cyclization of certain residues enhances its resistance to enzymatic degradation, making it more stable in physiological conditions. This peptide may exhibit specific pharmacological properties, potentially acting as a modulator in various biological pathways. Its design suggests applications in therapeutic contexts, particularly in areas related to peptide-based drugs or research in biochemistry and molecular biology. Further studies would be necessary to elucidate its precise mechanisms of action and potential uses in clinical settings.

<p>Please enquire for more information about Tyr-Lys-Gly-(Cyclo(Glu26-Lys29),Pro34)-Neuropeptide Y (25-36) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

CAS 185032-24-0

H-TYR-LYS-GLY-ARG-CYCLO(-GLU-TYR-ILE-LYS)-LEU-ILE-THR-ARG-PRO-ARG-TYR-NH2

Tyr-Lys-Gly-(Cyclo(Glu26-Lys29),Pro34)-Neuropeptide Y (25-36) trifluoroacetate salt

Ref: 3D-FT109137